ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Libya still in the mire as another anniversary passes – Yahoo News

Continue reading

2017-02-15 Michael Zand NEWS

UNC Charlotte Research Could Help Extend Storage Times For Transplant Donor Organs – WFAE

Libya still in the mire as another anniversary passes
Yahoo News
“Whether or not this state of suspended animation marks the beginning of Libya as a ‘failed state’ depends primarily on its economic standing,” she said. “The risk of a further deterioration of the country’s economy is real despite the uptick in oil …

and more »

Continue reading

2017-02-15 Michael Zand NEWS

Libya still in the mire as another anniversary passes – New Vision

UNC Charlotte Research Could Help Extend Storage Times For Transplant Donor Organs
WFAE
“You essentially put it into suspended animation so you don’t have the degradation that occurs when you’re holding it on ice,” says Gloria Elliott, director of the Charlotte Bank’s initiative. She says technology using cryogenic temperatures of 100-150 …

Continue reading

2017-02-15 Michael Zand NEWS

Immunotherapy slow, but effective, against hay fever – UPI.com

Libya still in the mire as another anniversary passes
New Vision
“Whether or not this state of suspended animation marks the beginning of Libya as a ‘failed state’ depends primarily on its economic standing,” she said. “The risk of a further deterioration of the country’s economy is real despite the uptick in oil …

and more »

Continue reading

2017-02-15 Michael Zand NEWS

Penn Medicine’s ODC collaborates with FAST to develop gene therapy for Angelman syndrome – News-Medical.net


The Hippocratic Post (blog)

Immunotherapy slow, but effective, against hay fever
UPI.com
TUESDAY, Feb. 14, 2017 — Immunotherapy — often in the form of allergy shots — can combat the runny nose, itchy eyes, congestion, sneezing and sinus pressure of persistent hay fever. But it can’t be done in less than three years, British researchers …
Longer immunotherapy for hay feverThe Hippocratic Post (blog)
Hay fever symptoms can be significantly reduced after three years of treatment, research suggestsThe Independent
Pollen pills suppresses hay fever for years – new reportTelegraph.co.uk
The Missouri Injury Blog (blog)
all 10 news articles »
Continue reading

2017-02-15 Michael Zand NEWS

Longer immunotherapy for hay fever – The Hippocratic Post (blog)

The Hippocratic Post (blog)Longer immunotherapy for hay feverThe Hippocratic Post (blog)Immunotherapy, which was first trialled on hay fever patients in London in 1911, has an excellent record in helping reduce allergy symptoms. But how long it works a… Continue reading

2017-02-15 Michael Zand NEWS

Immunotherapy Needs a New Math – OncLive

OncLiveImmunotherapy Needs a New MathOncLiveHoward Kaufman, MD, chief surgical officer and associate director for clinical science, Rutgers Cancer Institute, helped to organize a Value Summit on the issue at the November 2016 annual meeting of the Soci… Continue reading

2017-02-15 Michael Zand NEWS

AJ Foyt planning to undergo stem cell therapy – USA TODAY

USA TODAYAJ Foyt planning to undergo stem cell therapyUSA TODAYAdult stem cells are able to grow and become a cell for a specific tissue or organ, according to the National Institutes of Health. They are different from embryonic stem cells, which come … Continue reading

2017-02-15 Michael Zand NEWS
  • 1
  • …
  • 2,101
  • 2,102
  • 2,103
  • 2,104
  • 2,105
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

News-Medical.net

Penn Medicine’s ODC collaborates with FAST to develop gene therapy for Angelman syndrome
News-Medical.net
Penn Medicine’s Orphan Disease Center (ODC) announces a new partnership with FAST (Foundation for Angelman Syndrome Therapeutics) to study gene therapy approaches to treat Angelman syndrome (AS). FAST will provide funding to establish a gene …
Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman SyndromeNewswise (press release)

all 3 news articles »